2021
DOI: 10.1111/cas.15197
|View full text |Cite
|
Sign up to set email alerts
|

Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1‐STAT1 loop in lung adenocarcinoma

Abstract: This is an open access article under the terms of the Creat ive Commo ns Attri bution-NonCo mmercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 61 publications
0
6
0
Order By: Relevance
“…9,42 We reported that AKT1 knockdown attenuated the nuclear accumulation of KPNA2 in radioresistant lung cancer cells. 44 Our recent study found that acetylation of KPNA2 at lysine 22 and phosphorylation at serine 105 regulate the migration and nucleocytoplasmic distribution of KPNA2 in lung adenocarcinomas cells, 27 suggesting that post-translational modifications of KPNA2 are important in cancer biology. Based on mass spectrometry analyses, quantitative tissue phosphoproteome studies showed that KPNA2 phosphorylation at S62 was higher in breast cancer tissues 45,46 and colon cancer tissues 47 than in normal tissues.…”
Section: Discussionmentioning
confidence: 98%
“…9,42 We reported that AKT1 knockdown attenuated the nuclear accumulation of KPNA2 in radioresistant lung cancer cells. 44 Our recent study found that acetylation of KPNA2 at lysine 22 and phosphorylation at serine 105 regulate the migration and nucleocytoplasmic distribution of KPNA2 in lung adenocarcinomas cells, 27 suggesting that post-translational modifications of KPNA2 are important in cancer biology. Based on mass spectrometry analyses, quantitative tissue phosphoproteome studies showed that KPNA2 phosphorylation at S62 was higher in breast cancer tissues 45,46 and colon cancer tissues 47 than in normal tissues.…”
Section: Discussionmentioning
confidence: 98%
“…Based on current evidence, it is difficult to predict when PLSCR1 overexpression or inhibition would be beneficial in human disease since PLSCR1 function may vary according to cell types and disease processes. Nevertheless, a number of reports have highlighted the possible beneficial effects of PLSCR1 targeting in colorectal cancers, hepatic cancers, and lung adenocarcinoma, where blockade or silencing of this protein resulted in the inhibition of tumor growth and metastasis [ 19 , 79 , 80 , 91 ].…”
Section: Discussionmentioning
confidence: 99%
“…This PLSCR1-STAT3 axis was confirmed by Liao et al . , who demonstrated that karyopherin-α2 promoted radioresistance in lung adenocarcinoma by boosting PLSCR1-STAT3-mediated induction of STAT1-dependent signaling [ 79 ]. In a pilot study by Huang et al .…”
Section: Plscr1 Interactions With Endogenous Proteinsmentioning
confidence: 99%
“…Based on cell-cluster-markers and TAMs-related-genes, TOP 8 genes (C1QTNF6, CCNB1, FSCN1, HMMR, KPNA2, PRC1, RRM2, and TK1) significantly associated with prognosis were obtained (Figure 2). These have obvious benefits to clinicians for the assessment of patient prognosis (36)(37)(38)(39)(40)(41)(42)(43)(44)(45)(46)(47)(48)(49). The same data were used to construct a risk score model containing 9 factors (C1QTNF6, FSCN1, KPNA2, GLI2, TYMS, BIRC3, RBBP7, KRT8, and GPR65) for prognostic evaluation (Figure 2) (50)(51)(52)(53)(54)(55).…”
Section: Discussionmentioning
confidence: 99%